Very early molecular responses in the first two months of therapy are highly predictive of deep molecular responses at 18 months, in chronic myeloid leukemia patients treated upfront with nilotinib

dc.contributor.author	Sastre Moral, José Luis
dc.date.accessioned	2017-06-07T06:57:55Z
dc.date.available	2017-06-07T06:57:55Z
dc.date.issued	2014
dc.identifier.issn	0390-6078
dc.identifier.uri	http://hdl.handle.net/20.500.11940/1107
dc.language.iso	eng
dc.title	Very early molecular responses in the first two months of therapy are highly predictive of deep molecular responses at 18 months, in chronic myeloid leukemia patients treated upfront with nilotinib
dc.type	Publicación de congreso
dc.authorsophos	Steegmann, J. L.
dc.authorsophos	Casado Montero, L. F.
dc.authorsophos	Gomez-Casares, M. T.
dc.authorsophos	Rozman, M.
dc.authorsophos	Echeveste, M. A.
dc.authorsophos	Garcia-Gutierrez, V.
dc.authorsophos	Sastre, J. L.
dc.authorsophos	Ramirez Payer, A.
dc.authorsophos	Olavarria, E.
dc.authorsophos	Val, F.
dc.authorsophos	Xicoy, B.
dc.authorsophos	Giraldo, P.
dc.authorsophos	Conde, E.
dc.authorsophos	Omar Vallansot, R.
dc.authorsophos	Lorenzo, J. L.
dc.authorsophos	Palomera, L.
dc.authorsophos	Ruiz, S.
dc.authorsophos	Casas, L.
dc.authorsophos	Walasek, C.
dc.authorsophos	Colomer, D.
dc.identifier.isi	:000342830900182
dc.identifier.sophos	17037
dc.issue.number	S1
dc.journal.title	Haematologica
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Ourense - Complexo Hospitalario Universitario de Ourense::Hematoloxía clínica
dc.page.initial	75
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	99

Files in this item

Files	Size	Format	View
There are no files associated with this item.